title: Field molecular epidemiology. Feasibility of monitoring for the malignant bladder cell phenotype in a benzidine-exposed occupational cohort.
abstract: Modern molecular and cellular biology have provided powerful new approaches to study cancer in the research laboratory, but these techniques have not been used extensively in field studies or in screening of high-risk occupational cohorts. The primary objective of this study was to demonstrate the use of cellular and molecular methods in combination with medical and epidemiologic methods to identify cancer cases, risk factors, and markers in a previously identified and defined cohort of Chinese workers exposed to benzidine. The screening of exposed workers included occupational, medical, and smoking histories to identify exogenous risk factors, a limited physical examination, Papanicolaou (PAP) urinary cytology, measurement of urine pH, quantitative fluorescence image analysis (QFIA) cytology to detect DNA hyperploidy, and quantitative fluorescence to detect expression of a low-grade bladder tumor-associated antigen (p300) by exfoliated urothelial cells and elevated expression of the neu oncogene product (p185). Detailed analysis of the accuracy of epidemiologic data and the adequacy of samples and accuracy of molecular techniques was carried out. Three groups were included in this study: group 1 included 23 bladder cancer cases who had previously been exposed to benzidine and served as two surrogates for late-emerging disease; group 2 consisted of 20 subjects with previous exposure history but not previously diagnosed with bladder cancer; and group 0 was the nonexposure and nonbladder cancer controls. The results showed that accurate questionnaire data and urine samples can be obtained at remote sites. Among the 20 group 2 subjects, two displayed abnormal findings by both QFIA cytology and p300 expression and were later confirmed to have bladder cancer.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Toxicology and Epidemiology, Chinese Academy of Preventive Medicine, Beijing.
authors.forename: W
authors.initials: W
authors.lastname: Bi
authors.forename: J Y
authors.initials: JY
authors.lastname: Rao
authors.forename: G P
authors.initials: GP
authors.lastname: Hemstreet
authors.forename: P
authors.initials: P
authors.lastname: Fang
authors.forename: N R
authors.initials: NR
authors.lastname: Asal
authors.forename: M
authors.initials: M
authors.lastname: Zang
authors.forename: K W
authors.initials: KW
authors.lastname: Min
authors.forename: Z
authors.initials: Z
authors.lastname: Ma
authors.forename: E
authors.initials: E
authors.lastname: Lee
authors.forename: G
authors.initials: G
authors.lastname: Li
mesh_terms: D001560:Benzidines / Q000009:adverse effects; D014408:Biomarkers, Tumor / Q000652:urine*; D002681:China; D015331:Cohort Studies; D004273:DNA, Neoplasm / Q000032:analysis / Q000235:genetics; D000939:Epitopes / Q000032:analysis; D005453:Fluorescence; D006801:Humans; D008297:Male; D008991:Monitoring, Physiologic; D009784:Occupational Diseases / Q000139:chemically induced / Q000175:diagnosis; D016273:Occupational Exposure; D010865:Pilot Projects; D011003:Ploidies; D011518:Proto-Oncogene Proteins / Q000032:analysis; D018719:Erb-b2 Receptor Tyrosine Kinases; D013048:Specimen Handling; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced / Q000175:diagnosis*
chemical_list: D001560:Benzidines; D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm; D000939:Epitopes; D011518:Proto-Oncogene Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases